APA (7th ed.) Citation

Saisho, Y., Katsube, T., White, S., Fukase, H., & Shimada, J. (2018). Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects. Antimicrobial agents and chemotherapy, 62(3), . https://doi.org/10.1128/AAC.02163-17

Chicago Style (17th ed.) Citation

Saisho, Yutaka, Takayuki Katsube, Scott White, Hiroyuki Fukase, and Jingoro Shimada. "Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects." Antimicrobial Agents and Chemotherapy 62, no. 3 (2018). https://doi.org/10.1128/AAC.02163-17.

MLA (9th ed.) Citation

Saisho, Yutaka, et al. "Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects." Antimicrobial Agents and Chemotherapy, vol. 62, no. 3, 2018, https://doi.org/10.1128/AAC.02163-17.